129 related articles for article (PubMed ID: 37726197)
1. Endometrial adenocarcinoma recurring in the lung: impact of molecular profile and role of local therapies on prognosis.
Luzarraga Aznar A; Bebia V; López-Gil C; Giraldo A; Montoya MP; Verges R; Jauregui A; Castellvi J; Pérez-Benavente A; Colás E; Gil-Moreno A; Cabrera S
Int J Gynecol Cancer; 2023 Oct; 33(10):1564-1571. PubMed ID: 37726197
[TBL] [Abstract][Full Text] [Related]
2. Molecular profile is a strong predictor of the pattern of recurrence in patients with endometrial cancer.
Luzarraga Aznar A; Bebia V; López-Gil C; Villafranca-Magdalena B; Salazar-Huayna L; Castellvi J; Colàs E; Gil-Moreno A; Cabrera S
Int J Gynecol Cancer; 2024 May; 34(5):659-666. PubMed ID: 38378696
[TBL] [Abstract][Full Text] [Related]
3. Combination of Proactive Molecular Risk Classifier for Endometrial cancer (ProMisE) with sonographic and demographic characteristics in preoperative prediction of recurrence or progression of endometrial cancer.
Eriksson LSE; Nastic D; Lindqvist PG; Imboden S; Järnbert-Pettersson H; Carlson JW; Epstein E
Ultrasound Obstet Gynecol; 2021 Sep; 58(3):457-468. PubMed ID: 33314410
[TBL] [Abstract][Full Text] [Related]
4. Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes.
Smart A; Buscariollo D; Alban G; Buzurovic I; Cheng T; Pretz J; Krechmer B; King M; Lee L
Int J Gynecol Cancer; 2020 Dec; 30(12):1908-1914. PubMed ID: 32655012
[TBL] [Abstract][Full Text] [Related]
5. Mucinous adenocarcinoma of the endometrium: case series and review of the literature.
Jalloul RJ; Elshaikh MA; Ali-Fehmi R; Haley MM; Yoon J; Mahan M; Munkarah AR
Int J Gynecol Cancer; 2012 Jun; 22(5):812-8. PubMed ID: 22569105
[TBL] [Abstract][Full Text] [Related]
6. Role of adjuvant radiotherapy in FIGO stage IIIC endometrial carcinoma: Treatment outcomes and prognostic factors in 52 irradiated patients.
Hsieh HY; Wang L; Lu CH; Lin JC; Chen CC
J Formos Med Assoc; 2018 Jul; 117(7):613-620. PubMed ID: 28867455
[TBL] [Abstract][Full Text] [Related]
7. Recurrent endometrial cancer after surgery alone: results of salvage radiotherapy.
Jereczek-Fossa B; Badzio A; Jassem J
Int J Radiat Oncol Biol Phys; 2000 Sep; 48(2):405-13. PubMed ID: 10974454
[TBL] [Abstract][Full Text] [Related]
8. Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer.
Chung YS; Woo HY; Lee JY; Park E; Nam EJ; Kim S; Kim SW; Kim YT
Am J Obstet Gynecol; 2021 Apr; 224(4):370.e1-370.e13. PubMed ID: 33039397
[TBL] [Abstract][Full Text] [Related]
9. Increased risk of recurrence in early-stage endometrial carcinoma after delays in adjuvant radiation treatment.
Zhu S; Khalil R; Altairy O; Burmeister C; Dimitrova I; Elshaikh M
Int J Gynecol Cancer; 2021 Jan; 31(1):73-77. PubMed ID: 33087415
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for tumor recurrence in endometrioid endometrial cancer stages IA and IB.
Han KH; Kim HS; Lee M; Chung HH; Song YS
Medicine (Baltimore); 2017 May; 96(21):e6976. PubMed ID: 28538399
[TBL] [Abstract][Full Text] [Related]
11. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
12. An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma.
Liang LW; Perez AR; Cangemi NA; Zhou Q; Iasonos A; Abu-Rustum N; Alektiar KM; Makker V
Int J Gynecol Cancer; 2016 Mar; 26(3):497-504. PubMed ID: 26825840
[TBL] [Abstract][Full Text] [Related]
13. Impact of molecular profile on prognosis and relapse pattern in low and intermediate risk endometrial cancer.
Lindemann K; Kildal W; Kleppe A; Tobin KAR; Pradhan M; Isaksen MX; Vlatkovic L; Danielsen HE; Kristensen GB; Askautrud HA
Eur J Cancer; 2024 Mar; 200():113584. PubMed ID: 38330767
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.
Kuku S; Williams M; McCormack M
Int J Gynecol Cancer; 2013 Jul; 23(6):1056-64. PubMed ID: 23765205
[TBL] [Abstract][Full Text] [Related]
15. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
[TBL] [Abstract][Full Text] [Related]
16. [Predictors of recurrence and prognosis in patients with stage I and II endometrial carcinoma].
Li M; Wang Z; Zhao L; Li X; Wang J; Zhang C; Wei L
Zhonghua Fu Chan Ke Za Zhi; 2014 Jun; 49(6):455-9. PubMed ID: 25169640
[TBL] [Abstract][Full Text] [Related]
17. Survival Outcomes Improved in Contemporary Cohort of Patients With Pelvic or Abdominal Recurrence After Treatment for Stage I/II Endometrial Carcinoma.
Xu MJ; Chu C; Rubin S; Lin LL
Am J Clin Oncol; 2017 Dec; 40(6):598-604. PubMed ID: 26237194
[TBL] [Abstract][Full Text] [Related]
18. Isolated tumor cells and micrometastases in regional lymph nodes in stage I to II endometrial cancer.
Todo Y; Kato H; Okamoto K; Minobe S; Yamashiro K; Sakuragi N
J Gynecol Oncol; 2016 Jan; 27(1):e1. PubMed ID: 25925293
[TBL] [Abstract][Full Text] [Related]
19. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.
Creutzberg CL; van Putten WL; Koper PC; Lybeert ML; Jobsen JJ; Wárlám-Rodenhuis CC; De Winter KA; Lutgens LC; van den Bergh AC; van de Steen-Banasik E; Beerman H; van Lent M
Lancet; 2000 Apr; 355(9213):1404-11. PubMed ID: 10791524
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer.
Stasenko M; Tunnage I; Ashley CW; Rubinstein MM; Latham AJ; Da Cruz Paula A; Mueller JJ; Leitao MM; Friedman CF; Makker V; Soslow RA; DeLair DF; Hyman DM; Zamarin D; Alektiar KM; Aghajanian CA; Abu-Rustum NR; Weigelt B; Cadoo KA
Gynecol Oncol; 2020 Jan; 156(1):194-202. PubMed ID: 31757464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]